This symposium will focus on the use of heparin management strategies to optimize patient outcomes via multiple testing techniques. Implementation of Anti-Xa testing for heparin monitoring and heparin-related complications will be covered.

Following the workshop, Werfen representatives will be available online to answer questions.

Date

October 24, 2023

Objectives

• Define the benefits of Anti-Xa testing for heparin monitoring.
• Highlight the health-economic benefits of Anti-Xa versus aPTT testing for heparin monitoring.
• Discuss the diagnosis and management of heparin-induced thrombocytopenia, with case examples.